Feeder free expansion and closed wash and concentration of a clinically relevant number of human NK cells


One of the key challenges faced by the cell and gene therapy industry is the ability to expand and process NK cells using regulation-compliant reagents and closed manufacturing systems. In this presentation, we will discuss how CTS™ NK-Xpander™ Medium and the CTS™ Rotea™ Counterflow Centrifugation System increase the ability to generate and process large numbers of functionally viable human NK cells, filling a need for translational researchers to bring NK adoptive cell therapies to the clinic.

View More
View Less

Share this video